Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-04-15 Option Award | 2021-04-19 4:52 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer | 244,300 | $0 | 244,300 (Direct) | View |
| 2021-03-17 Option Award | 2021-03-19 4:58 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer | 16,001 | $0 | 25,792 (Direct) | View |
| 2021-03-17 Disposition | 2021-03-19 4:58 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer | 16,001 | $0 | 25,792 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-15 7:38 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer | 16,002 | $0 | 25,792 (Direct) | View |
| 2020-06-12 Tax Withholding | 2020-06-15 7:38 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer | 6,211 | $3.46 | 25,792 (Direct) | View |
| 2020-06-12 Disposition | 2020-06-15 7:38 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer | 16,002 | $0 | 25,792 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:04 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin EVP of R&D | 106,100 | $0 | 106,100 (Direct) | View |
| 2019-09-21 Option Award | 2019-09-24 5:15 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin EVP of R&D | 32,003 | $0 | 32,003 (Direct) | View |